# GPT-5.4 (R1) Review

**Role:** External referee review
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-28T01:49:03.274126
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 15911 in / 4990 out
**Response SHA256:** b2bfa458c4950de1

---

This paper studies whether online sports betting (OSB) legalization increases alcohol-involved fatal crashes using FARS data from 2013–2022 and staggered adoption across 18 states. The paper’s main substantive message is twofold: (i) a positive average effect of OSB legalization on alcohol-involved fatal crashes, and (ii) a rejection of the “game-day bar attendance” mechanism emphasized in the earlier version.

The paper is ambitious, policy-relevant, and commendably transparent about correcting an earlier false positive. The discussion of exposure normalization in mechanism tests is genuinely useful. That said, for a top general-interest journal or AEJ: Economic Policy, the paper is not yet publication-ready. The central causal claim remains more weakly identified than the draft acknowledges, the mechanism rejection is not as definitive as claimed, and inference/diagnostics need to be strengthened substantially.

## 1. Identification and empirical design

### A. Baseline staggered DiD: plausible but not yet fully credible for the stated causal claim

The paper uses the Callaway-Sant’Anna estimator with never-treated states as the primary control group and not-yet-treated states as a robustness check (Section 5). This is the correct broad direction given staggered treatment timing, and it avoids the most obvious TWFE contamination problem. That is a strength.

However, the identification argument is still incomplete for a strong causal interpretation.

#### 1. Parallel trends is asserted, not demonstrated in a sufficiently persuasive way
The paper repeatedly states that pre-trends are flat and “jointly insignificant” (Sections 5 and 6), but the manuscript provides no reported pre-trend test statistics, no cohort-specific pre-trend evidence, and no discussion of the power of those pre-trend tests. For a top journal, “visual flatness” or a narrative statement is not enough, especially when treatment adoption is politically endogenous.

Relatedly, the paper’s own institutional discussion acknowledges likely confounding policy bundles in adopting states—cannabis legalization, alcohol rules, DUI reforms, interlocks, ride-share market entry, etc. (Section 3, “Concurrent policy environment”). That is exactly the set of concerns that make pre-trend and covariate-balance diagnostics essential rather than optional.

**Why this matters:** states legalizing OSB may be on distinct trajectories in alcohol-related risk, nightlife activity, or regulatory permissiveness. Non-alcohol crashes are an informative placebo, but they do not rule out confounders that differentially affect alcohol-involved crashes.

#### 2. The paper’s treatment timing is coarse and may create serious attenuation/composition issues
Treatment begins in the quarter containing launch (Section 3, “Treatment definition”). This is a consequential choice because many launch dates occur late in quarter (e.g., Maryland on November 23, 2022; New Hampshire on December 30, 2019). Coding the entire quarter as treated when only a small fraction is actually exposed creates nonclassical measurement error in treatment timing and makes dynamic effects around event time 0–1 difficult to interpret.

This matters even more because the paper interprets weak immediate effects and stronger later effects as evidence of gradual market penetration (Section 6). But with quarter-level treatment coding, part of that pattern may simply reflect partial-quarter exposure rather than true dynamics.

**Concrete concern:** states with one or two post-treatment quarters are especially fragile under quarterly coding. Kansas and Maryland contribute very little exposed time, and Maryland’s “one treated quarter” is mostly pre-launch calendar time.

A more credible design would move to monthly, or ideally daily/weekly, state panels for the main treatment effect, using exact launch dates. The paper already uses higher-frequency data for mechanism analysis, which underscores that the quarter-level baseline is a convenience, not a necessity.

#### 3. The “never-treated” group is not a clean control conceptually
The never-treated group includes six states that legalize after the sample ends and are treated as never-treated throughout (Sections 3 and Appendix Table A1). That is defensible mechanically, but substantively these are future adopters—likely more similar to treated states than true never-adopters. That can be helpful, but it also reinforces the need to show results under multiple comparison sets and to discuss composition.

The manuscript does include not-yet-treated estimates (Table 5), which is good. But the paper does not show enough detail on how sensitive the estimates are to restricting controls to future adopters only, to never-adopters only, or to geographically/politically similar states. Those are important design diagnostics here.

#### 4. Omitted concurrent policy changes are a major identification threat, and the current response is not sufficient
The paper explicitly notes it does not directly control for other policy changes that may affect alcohol-involved crashes (Section 3). The draft argues that the non-alcohol placebo mitigates this because omitted policies would need to selectively affect alcohol-related crashes.

This is too strong. Many plausible confounders do exactly that: changes in alcohol availability, cannabis-alcohol interactions, DUI enforcement, or ride-share penetration could affect alcohol-involved fatalities much more than non-alcohol ones. The non-alcohol placebo is helpful, but it does not “solve” the omitted-policy problem.

At minimum the paper needs:
- a richer discussion of major coincident policy changes in treated states,
- controls or event-study overlays for leading alternative policies,
- or sample restrictions excluding states with major coincident policy shifts.

Without that, the causal interpretation should be more cautious.

### B. The mechanism design is directionally good, but the “rejection” claim is overstated

The paper’s correction of the earlier game-day triple-difference is valuable. The exposure-normalization point is correct and important. However, the current mechanism test is not sharp enough to support the strong claim that the game-day mechanism is rejected.

#### 1. NFL “game day” is measured with a coarse proxy, not actual schedules
Section 4 states that game days are classified from the “known structure of the NFL calendar” rather than exact game-by-game schedules, and the paper calls this a conservative test. I do not agree that this is adequate for a paper whose headline contribution is the rejection of a calendar-based mechanism.

Using Sundays, Mondays, Thursdays, and some Saturdays during the season is a noisy proxy for actual exposure to salient betting opportunities. It ignores:
- exact game dates,
- game timing,
- local team schedules,
- high-salience playoff/postseason dates,
- and betting activity in other sports (college football, NBA, March Madness, MLB playoffs).

Measurement error in the mechanism regressor biases interaction estimates toward zero. Given the paper’s central contribution is a null mechanism finding, this is a first-order problem.

#### 2. The mechanism hypothesis tested is narrower than the broader “sports betting complements alcohol” hypothesis
The paper moves from “no NFL game-day concentration” to “the game-day bar attendance hypothesis fails” and at points suggests broader mechanism rejection (Abstract, Introduction, Sections 6–8). But the tests target only a narrow NFL-specific event-timing version of the mechanism.

A plausible complementarity channel could still exist through:
- college football Saturdays,
- NBA or other sports,
- general sports-bar culture,
- advertising spikes,
- or same-day/in-play betting not limited to NFL windows.

The late-night and weekend concentration in Table 4 is actually consistent with some alcohol-complementarity stories; it does not isolate which one. The manuscript should recalibrate and say it rejects a narrow NFL-broadcast-day concentration hypothesis, not the broader complementarity mechanism.

#### 3. Triple-difference structure needs more justification
Equation (2) includes state, time, and game-day fixed effects with OSB and OSB×GameDay. But the text does not explain clearly what “time FE” means in the DDD—quarter FE? week FE? season-quarter FE? Given strong seasonality and day-type differences in crashes, the choice matters. If time FE are only quarter FE, residual confounding from within-season timing remains possible.

A cleaner test would use exact date-level data with:
- state FE,
- date FE or at least week-by-year FE,
- and state-specific seasonality controls,
plus event-level exposure definitions based on actual schedules.

## 2. Inference and statistical validity

### A. Main estimates report uncertainty, but inference still needs upgrading

The baseline estimates report standard errors (Table 2), and clustered SEs at the state level are a sensible default. This is necessary and appreciated.

However, for publication at the target outlets, the current inference is not fully persuasive.

#### 1. Cluster-robust inference with only 18 treated states requires more care
There are 51 state clusters total, but only 18 treated states. In staggered-adoption settings, effective treatment variation is driven by treated clusters and treatment timing, not just total cluster count. The manuscript acknowledges wild cluster bootstrap was “attempted” but unavailable (Section 5, “Inference”). That is not sufficient.

For a paper that hangs on a modestly significant main estimate (0.380, SE 0.146), stronger small-sample-robust inference is required:
- wild cluster bootstrap,
- randomization inference / permutation tests based on treatment timing,
- or alternative finite-sample corrections.

A top journal will not accept “the package was unavailable” as a reason not to do this.

#### 2. Event-study uncertainty is underreported
Figure 1 is described as having 95% confidence intervals and jointly insignificant pre-trends, but the manuscript gives no formal pre-trend p-value, no number of cohorts contributing to each lead/lag, and no indication of support thinning at long horizons. In staggered designs, dynamic coefficients at long event times often become compositionally unstable.

The paper also interprets growing post-treatment effects as behavioral ramp-up. Without reporting cohort support and dynamic aggregation details, those dynamics are hard to evaluate.

#### 3. Multiple testing issues are not discussed
The paper conducts many secondary tests:
- non-alcohol placebo,
- fatality rate,
- share outcome,
- off-season placebo,
- NFL team heterogeneity,
- four time-of-day splits,
- weekend vs weekday,
- multiple mechanism specifications.

Individually these are informative, but the paper draws strong conclusions from a subset of marginal p-values (e.g., weekend p = 0.049; late night p = 0.024) without discussing multiple testing or the exploratory nature of decomposition exercises. This is especially relevant because the paper simultaneously argues that the mechanism tests are decisive and that the temporal decomposition reveals where the effect “lives.”

#### 4. Sample sizes across mechanism specifications need clarification
Table 3 reports 3,567 observations for the state-quarter-day DDD, which seems to reflect 51 states × 40 quarters × game-day status cells minus missingness, but the construction is not fully transparent. The Poisson specification has only 2,853 observations, which is a sizable drop relative to the OLS specification; the reason is not explained. This should be clarified.

Likewise, for the week panel (25,225 observations), it would help to state exactly how partial weeks are handled, whether exposure weeks with zero days are included, and how launch-week treatment coding works.

## 3. Robustness and alternative explanations

### A. Strengths
There are several meaningful robustness exercises:
- not-yet-treated controls,
- excluding COVID-era adopters,
- leave-one-out by treated state,
- non-alcohol placebo,
- off-season placebo for the DDD.

These are useful and improve confidence that the baseline result is not driven by one obvious coding error or one state.

### B. Key missing robustness checks

#### 1. No covariate-adjusted or matched-event-study version
Given the high risk of policy endogeneity, the paper should show baseline estimates with time-varying state controls or a more credible residualization strategy. Examples:
- unemployment,
- gas prices,
- VMT,
- alcohol taxes or sales restrictions,
- cannabis legalization status,
- ride-share penetration proxies,
- police/DUI enforcement proxies if available.

I agree controls do not solve everything, but not showing them leaves the paper exposed.

#### 2. No state-specific trends or flexible differential trends analysis
A standard check would assess whether results survive adding state-specific linear trends or interacting pre-period covariates with time. These are imperfect, but they are useful sensitivity analyses in a context where adopting states may evolve differently.

#### 3. No design-based placebo adoption tests
The paper should include placebo randomization/permutation tests that assign pseudo-adoption dates across states and show where the actual estimate lies in the null distribution. This is especially valuable given the moderate number of treated clusters and staggered timing.

#### 4. No exact-treatment-date main specification
This is perhaps the most important missing robustness check. Because the paper already emphasizes timing precision in the mechanism analysis, it is hard to justify keeping the main causal estimate at the quarter level only. A daily or monthly state panel with exact launch dates would both sharpen identification and eliminate partial-quarter treatment misclassification.

#### 5. Placebo outcomes are too limited
Non-alcohol crashes are a good placebo. Total crashes are less useful and, as the paper notes, not additive under separate DR weighting (Table 5). Additional placebo outcomes from FARS that should be considered:
- daytime non-alcohol crashes,
- single-vehicle non-alcohol crashes,
- crashes not plausibly related to drinking hours,
- passenger/pedestrian fatality composition.

These could help distinguish alcohol-specific channels from broader roadway changes.

## 4. Contribution and literature positioning

The paper’s contribution is potentially interesting:
1. a new estimate of a traffic-safety externality from OSB legalization;
2. a cautionary lesson on exposure normalization in mechanism tests;
3. evidence against a specific NFL game-day concentration story.

The methodological transparency about correcting the earlier result is admirable and unusual in a good way.

That said, the literature framing needs strengthening in two directions.

### A. Traffic safety and policy-evaluation literature is underdeveloped
The paper cites a few classic alcohol/fatality papers, but for a paper squarely about fatal motor vehicle crashes and policy shocks, the traffic-safety literature discussion is thinner than it should be. It should engage more directly with recent work on:
- alcohol policies and crash outcomes,
- cannabis legalization and traffic fatalities,
- ride-share entry and alcohol-related crashes,
- and policy evaluation using FARS with staggered timing.

Even if not all are direct analogues, the paper needs to situate itself among modern quasi-experimental traffic-safety studies.

### B. Sports betting literature should be more tightly differentiated
The paper cites Gruber, Baker et al., Swanson, Humphreys, but the precise novelty relative to work on gambling, drinking, and risky behaviors is still somewhat broad-brush. The manuscript should distinguish:
- direct effects of legalization vs online/mobile rollout,
- betting access vs advertising intensity,
- and financial distress vs consumption-complementarity channels.

### Concrete citations to consider adding
I am not certain which exact papers are in the bibliography database, but the paper should engage with work in the following areas:
- modern staggered-DiD diagnostics and aggregation beyond Callaway-Sant’Anna/Sun-Abraham;
- event-study pitfalls and pre-trend testing limitations;
- ride-sharing and DUI/fatality papers;
- cannabis legalization and alcohol-related traffic safety;
- recent sports-betting empirical work on health/risk-taking outcomes.

At minimum, the paper should cite methodological work on the weak informativeness of pre-trend tests and on robust inference with few treated clusters.

## 5. Results interpretation and claim calibration

This is where the paper currently overreaches most.

### A. The baseline result should be presented more cautiously as evidence consistent with a causal effect, not yet definitive causal proof
Given the omitted-policy concerns and treatment-timing coarseness, the repeated phrasing that the paper “documents” or “establishes” that OSB legalization increases alcohol-involved fatal crashes is too strong. The paper has suggestive and potentially important causal evidence, but not yet a fully airtight design.

### B. The mechanism “rejection” is overstated
The paper claims that “all three predictions fail” and that the game-day mechanism is rejected (Abstract, Introduction, Results, Conclusion). What is actually shown is:
- no detectable NFL calendar-day amplification using a coarse proxy,
- no strong heterogeneity by NFL team presence,
- no evening-hour concentration.

That is useful, but it does not reject broader alcohol-complementarity channels or more refined event-specific hypotheses. The language should be narrowed substantially.

### C. Welfare calculations are too aggressive relative to the evidence
Section 6.6 extrapolates to roughly 570 excess fatalities nationally across 18 states and a VSL cost of $6.6 billion. This is a very strong policy claim built on a point estimate with nontrivial identification uncertainty and notable heterogeneity in post-treatment exposure.

This section should be toned down or reframed as a back-of-the-envelope scenario analysis with clear uncertainty intervals. At a minimum, the paper should:
- report confidence intervals on implied fatality counts,
- avoid comparing point-estimate social costs directly to tax revenues without equal treatment of uncertainty and benefits,
- and emphasize this as illustrative, not a central conclusion.

### D. Some textual interpretations lean too heavily on nulls
Examples:
- “Whatever drives the increase operates specifically through the alcohol channel” (Section 6): too strong given measurement and omitted-policy concerns.
- “This null is the paper’s main finding” (Section 6.2): the null mechanism result is interesting, but the positive average effect remains the primary result.
- “The effect is not event-driven” (Section 6.2): too categorical given noisy mechanism measurement.

## 6. Actionable revision requests

### 1. Must-fix issues before acceptance

#### 1. Re-estimate the main effect at monthly or weekly frequency using exact launch dates
- **Issue:** Quarter-of-launch treatment coding induces substantial exposure misclassification.
- **Why it matters:** It affects the credibility of both the average effect and the dynamic/event-study interpretation.
- **Concrete fix:** Build a state-month or state-week panel from FARS using exact OSB launch dates; re-estimate main ATT and event study with exact timing.

#### 2. Strengthen inference with valid few-treated-cluster methods
- **Issue:** Conventional clustered SEs are not enough given only 18 treated states and a moderately sized main effect.
- **Why it matters:** The paper cannot clear publication-ready standards without stronger inference.
- **Concrete fix:** Implement wild cluster bootstrap, randomization inference over treatment timing, or equivalent finite-sample-robust methods for all main estimates and key mechanism tests.

#### 3. Address omitted concurrent-policy confounding directly
- **Issue:** The paper acknowledges but does not address major concurrent policies that could differentially affect alcohol crashes.
- **Why it matters:** This is the main threat to causal identification.
- **Concrete fix:** Add controls and/or exclusion analyses for cannabis legalization, major alcohol law changes, DUI reforms, and ride-share rollout proxies; provide a table of coincident policy changes by treated state.

#### 4. Replace coarse NFL proxy with exact schedule-based mechanism measures
- **Issue:** The headline null mechanism result relies on noisy classification of game days.
- **Why it matters:** Null results under severe measurement error cannot support strong rejection claims.
- **Concrete fix:** Use exact NFL schedules, game start/end times, local team games, playoffs, and ideally other major betting-relevant sports; re-estimate event-day and post-game-hour effects at daily/hourly frequency.

#### 5. Recalibrate claims throughout
- **Issue:** The manuscript claims stronger causal and mechanism conclusions than the evidence warrants.
- **Why it matters:** Claim calibration is central for publication readiness.
- **Concrete fix:** Rewrite the abstract, introduction, and conclusion to distinguish clearly between evidence for an average association consistent with a causal effect and a narrower rejection of NFL-specific timing concentration.

### 2. High-value improvements

#### 6. Report much fuller event-study diagnostics
- **Issue:** Pre-trend evidence is currently asserted rather than documented rigorously.
- **Why it matters:** Parallel-trends credibility is central.
- **Concrete fix:** Report formal joint pre-trend tests, cohort support by event time, dynamic aggregation details, and sensitivity of dynamics to balanced event windows.

#### 7. Add design-based placebo tests
- **Issue:** No permutation/placebo timing exercise is shown.
- **Why it matters:** This would materially strengthen confidence in the baseline estimate.
- **Concrete fix:** Randomly reassign adoption dates across states or use placebo treatment timing among control states and present the null distribution.

#### 8. Expand placebo outcomes and heterogeneity analyses
- **Issue:** Current falsification tests are informative but limited.
- **Why it matters:** Additional placebo margins could help discriminate alcohol-specific channels from general crash shifts.
- **Concrete fix:** Add placebo outcomes by non-alcohol nighttime/daytime crashes, crash type, and victim composition; explore heterogeneity by baseline drinking culture or alcohol regulation.

#### 9. Clarify observation counts and sample construction for mechanism panels
- **Issue:** N differs materially across mechanism specifications without explanation.
- **Why it matters:** Replicability and interpretation depend on understanding cell construction and missingness.
- **Concrete fix:** Add an appendix describing the exact construction of state-quarter-game-day and state-week panels, including treatment coding for partial periods.

### 3. Optional polish

#### 10. Tighten the distinction between online/mobile betting and general sports betting legalization
- **Issue:** The paper sometimes attributes effects to mobile OSB specifically, but treatment may also bundle broader legal-access changes.
- **Why it matters:** Precision about the treatment margin helps external validity.
- **Concrete fix:** Clarify in text where the estimated effect is of online launch versus broader legalization environment.

#### 11. Present uncertainty around welfare calculations
- **Issue:** Welfare numbers are presented as strong headline magnitudes.
- **Why it matters:** They can dominate reader takeaways despite identification uncertainty.
- **Concrete fix:** Move to an appendix or explicitly present as illustrative with confidence bounds and sensitivity ranges.

## 7. Overall assessment

### Key strengths
- Important and policy-relevant question.
- Appropriate avoidance of naive TWFE in the main staggered-adoption setting.
- Transparent correction of a prior false positive; the exposure-normalization lesson is genuinely valuable.
- Baseline result is reasonably stable across several sensible robustness checks.
- Good instinct to use placebo outcomes and temporal decomposition.

### Critical weaknesses
- Main identification is not yet strong enough for the paper’s causal claims.
- Treatment timing is too coarse for the stated design and available data.
- Inference is not publication-ready without stronger few-cluster methods.
- Mechanism rejection relies on noisy game-day measurement and is overclaimed.
- Concurrent policy confounding is acknowledged but insufficiently addressed.

### Publishability after revision
I think this project is salvageable and potentially publishable, but only after substantial redesign of the empirical implementation and a meaningful narrowing/recalibration of the claims. In its current form, it is not ready for acceptance or near-acceptance at the journals named in the prompt.

DECISION: MAJOR REVISION